368 related articles for article (PubMed ID: 9280214)
1. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
[TBL] [Abstract][Full Text] [Related]
2. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
[TBL] [Abstract][Full Text] [Related]
4. Determination of methylated arginines by column-switching high-performance liquid chromatography-fluorescence detection.
Tsunoda M; Nonaka S; Funatsu T
Analyst; 2005 Oct; 130(10):1410-3. PubMed ID: 16172667
[TBL] [Abstract][Full Text] [Related]
5. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.
Kato GJ; Wang Z; Machado RF; Blackwelder WC; Taylor JG; Hazen SL
Br J Haematol; 2009 May; 145(4):506-13. PubMed ID: 19344390
[TBL] [Abstract][Full Text] [Related]
6. Symmetric dimethylarginine is an independent predictor of intradialytic hypotension.
Mangoni AA; Hewitson CL; Woodman RJ; Whiting MJ; McAteer-Carr B; Barbara JA
Am J Hypertens; 2008 Aug; 21(8):955-9. PubMed ID: 18551101
[TBL] [Abstract][Full Text] [Related]
7. Effects of some guanidino compounds on human cerebral arteries.
Segarra G; Medina P; Ballester RM; Lluch P; Aldasoro M; Vila JM; Lluch S; Pelligrino DA
Stroke; 1999 Oct; 30(10):2206-10; discussion 2210-11. PubMed ID: 10512930
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
MacAllister RJ; Fickling SA; Whitley GS; Vallance P
Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
[TBL] [Abstract][Full Text] [Related]
9. Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia.
Masuda H; Tsujii T; Okuno T; Kihara K; Goto M; Azuma H
Am J Physiol Regul Integr Comp Physiol; 2002 Jun; 282(6):R1730-8. PubMed ID: 12010755
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment.
Nonaka-Hashida S; Sekine M; Ozeki Y; Fujii K; Akiyama K; Shimoda K; Tsunoda M; Katane M; Saitoh Y; Miyamoto T; Homma H
Psychiatry Res; 2016 Apr; 238():203-210. PubMed ID: 27086234
[TBL] [Abstract][Full Text] [Related]
12. Localization and role of nitric oxide synthase and endogenous nitric oxide synthase inhibitors in the rabbit lower urinary tract.
Masuda H; Tsujii T; Okuno T; Kihara K; Goto M; Azuma H
J Urol; 2002 May; 167(5):2235-40. PubMed ID: 11956485
[TBL] [Abstract][Full Text] [Related]
13. Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients.
Mittermayer F; Schaller G; Pleiner J; Vychytil A; Sunder-Plassmann G; Hörl WH; Wolzt M
J Am Soc Nephrol; 2005 Jun; 16(6):1832-8. PubMed ID: 15857920
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
[TBL] [Abstract][Full Text] [Related]
15. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
Jepson RE; Syme HM; Vallance C; Elliott J
J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic assay of N(G)-monomethyl-L-arginine, N(G),N(G)-dimethyl-L-arginine, and N(G),N(G)'-dimethyl-L-arginine using 4-fluoro-7-nitro-2, 1,3-benzoxadiazole as a fluorescent reagent.
Nonaka S; Tsunoda M; Imai K; Funatsu T
J Chromatogr A; 2005 Feb; 1066(1-2):41-5. PubMed ID: 15794553
[TBL] [Abstract][Full Text] [Related]
17. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
18. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure.
MacAllister RJ; Rambausek MH; Vallance P; Williams D; Hoffmann KH; Ritz E
Nephrol Dial Transplant; 1996 Dec; 11(12):2449-52. PubMed ID: 9017621
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients.
Anderstam B; Katzarski K; Bergström J
J Am Soc Nephrol; 1997 Sep; 8(9):1437-42. PubMed ID: 9294836
[TBL] [Abstract][Full Text] [Related]
20. [Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase].
Masuda H; Azuma H
Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):29-35. PubMed ID: 11862754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
